Inhibition of vascular smooth muscle cell proliferation, migration, and survival by the tumor suppressor protein PTEN

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 22, Issue 5, 2002, Pages 745-751

  Huang, Jianhua ^a   Kontos, Christopher D ^a,b  

^a Division of Cardiology   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Neointimal hyperplasia; p70s6k; Phosphatidylinositol 3 kinase; PTEN; Vascular smooth muscle cell

Indexed keywords

CASPASE 3; FOCAL ADHESION KINASE; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; S6 KINASE; VIRUS VECTOR;

ADENOVIRUS; ANIMAL CELL; APOPTOSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL MIGRATION; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GENE THERAPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RABBIT; RESTENOSIS; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; APOPTOSIS; CELL MIGRATION INHIBITION; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; DOWN-REGULATION; ENZYME INHIBITORS; FOCAL ADHESION KINASE 2; GENES, TUMOR SUPPRESSOR; GROWTH INHIBITORS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; PHOSPHORIC MONOESTER HYDROLASES; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RABBITS; RIBOSOMAL PROTEIN S6 KINASES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 0036094861     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000016358.05294.8D     Document Type: Article

References (51)

1. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome
2. Percutaneous coronary intervention in the current era compared with 1985-1986: The National Heart, Lung, and Blood Institute Registries
3. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model
4. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: A quantitative coronary angiography and three-dimensional intravascular ultrasound study
5. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: One-year angiographic and intravascular ultrasound follow-up
6. TOR a central controller of cell growth
7. TOR signaling and control of cell growth
8. Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k
9. Rapamycin selectively represses translation of the "polypyrimidine tract" mRNA family
10. Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway
11. Mammalian target of rapamycin is a direct target for protein kinase B: Identification of a convergence point for opposing effects of insulin and amino acid deficiency on protein translation
12. Phosphoinositide kinases
13. The role of phosphoinositide 3-kinase lipid products in cell function
14. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5- trisphosphate-dependent activation of protein kinase B
15. Phosphorylation and activation of p70s6k by PDK1
16. Mechanisms and consequences of activation of protein kinase B/Akt
17. The PI3K-PDK1 connection: More than just a road to PKB
18. Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin
19. Phosphatidylinositol 3-kinase signaling is important for smooth muscle cell replication after arterial injury
20. Phosphatidylinositol 3-kinases in tumor progression
21. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
22. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
23. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer
24. PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3- kinase/Akt-dependent and -independent pathways
25. The turnout suppressor gene PTEN can regulate cardiac hypertrophy and survival
26. PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects
27. In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction
28. HCPTPA a protein tyrosine phosphatase that regulates VEGF receptor-mediated signal transduction and biological activity
29. Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration
30. Phosphatidylinositol 3-kinase is required for insulin-like growth factor-I-induced vascular smooth muscle cell proliferation and migration
31. Platelet-derived growth factor-BB (PDGF-BB) regulation of migration and focal adhesion kinase phosphorylation in rabbit aortic vascular smooth muscle cells: Roles of phosphatidylinositol 3-kinase and mitogen-activated protein kinases
32. Phosphatidylinositol 3-kinase and focal adhesion kinase are early signals in the growth factor-like responses to thrombospondin-1 seen in human vascular smooth muscle
33. Requirement of phosphatidylinositol 3-kinase in focal adhesion kinase-promoted cell migration
34. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway
35. Cell cycle progression: New therapeutic target for vascular proliferative disease
36. The emerging concept of vascular remodeling
37. Role of phosphoinositide 3-kinase in activation of ras and mitogen-activated protein kinase by epidermal growth factor
38. Signaling through the lipid products of phosphoinositide-3-OH kinase
39. The modular phosphorylation and activation of p70s6k
40. Phosphatidylinositol 3-kinases regulate ERK and p38 MAP kinases in canine colonic smooth muscle
41. Hepatocyte growth factor/scatter factor stimulates migration of rat mammary fibroblasts through both mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt pathways
42. The Ras/phosphatidylinositol 3-kinase, and Ras/ERK pathways function as independent survival modules each of which inhibits a distinct apoptotic signaling pathway in sympathetic neurons
43. Differential requirements of the MAP kinase and PI3 kinase signaling pathways in Sr- versus insulin and IGF-1 receptors-induced growth and transformation of rat intestinal epithelial cells
44. Cell replication in the arterial wall: Activation of signaling pathway following in vivo injury
45. PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase
46. Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury
47. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty
48. Inhibition of neointimal smooth muscle accumulation after angioplasty by an antibody of PDGF
49. Recombinant platelet-derived growth factor B gene expression in porcine arteries induce intimal hyperplasia in vivo
50. Mechanism of action and in vivo role of platelet-derived growth factor
51. Platelet-derived growth factor (PDGF): Actions and mechanisms in vascular smooth muscle